DT interview 11th Feb, page-19

so we have operon already doing a desk top run and are about to move to mass scale reel to reel production. we have teams in Europe setting up distribution networks. not in this video but we will have manufacturing in Australia (ellume).

we have 3 tests in play swab, saliva and multiplex covid/flu

VIDRL has always been our clinical trial partner but Derek mentioned Doherty as well. ( Doherty institute is used by he TGA to assess new tests in Aust.)

also 1st mention of entering the US market. we have had the US mentioned in initial testing companies at the same time as licensing deals were discussed.

also the 1st mention of Asia being considered. I have noticed Veritas being interested in our last few announcements.

each time I try to work out where Anteotech sp could end up more information is given with the possibilities continuously expanding. so much to look forward to, with the sp currently sitting at 20.5c. unreal......